Exfoliation syndrome in the Reykjavik Eye Study: Risk factors for baseline prevalence and 5-year incidence

British Journal of Ophthalmology

Volumn 94, Issue 7, 2010, Pages 831-835

  Arnarsson, Arsaell ^a,b   Jonasson, Fridbert ^a   Damji, Karim F ^c   Gottfredsdottir, Maria S ^a   Sverrisson, Thordur ^a   Sasaki, Hiroshi ^d  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF AKUREYRI   (Iceland)

^c UNIVERSITY OF ALBERTA   (Canada)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; BODY MASS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; EXFOLIATION SYNDROME; FEMALE; FOLLOW UP; HIGH FIBER DIET; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYDRIASIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SELF REPORT; SEX DIFFERENCE; SLIT LAMP; SMOKING; VEGETABLE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; DIET; EPIDEMIOLOGIC METHODS; EXFOLIATION SYNDROME; EYE COLOR; FEMALE; FRUIT; HUMANS; ICELAND; MALE; MIDDLE AGED; SEX FACTORS; VEGETABLES;

EID: 77954274718     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.157636     Document Type: Article

References (25)

1. Schlötzer-Schrehardt U, Naumann GOH. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006;141:921-37.
2. Lee RK. The molecular pathophysiology of pseudoexfoliation glaucoma. Curr Opin Ophthalmol 2008;19:95-101.
3. Streeten BW, Li ZY, Wallace RN, et al. Pseudoexfoliative fibrillopathy in the visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992;110:1757-62.
4. Schlötzer-Schrehardt UM, Koca MR, Naumann GO, et al. Pseudoexfoliation syndrome. ocular manifestation of a systemic disorder? Arch Ophthalmol 1992;110:1752-6.
5. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997;124:685-7.
6. Linner E, Popovic V, Gottfries C-G, et al. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand 2001;79:283-5.
7. Ritland JS, Egge K, Lydersen S, et al. Exfoliative glaucoma and primary open-angle glaucoma: Associations with death causes and comorbidity. Acta Ophthalmol Scand 2004;82:401-4.
8. Visontai Z, Merisch B, Kollai M, et al. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol 2006;90:563-7.
9. Arnarsson A, Damji KF, Sverrisson T, et al. Pseudoexfoliation in the Reykjavik Eye Study: Prevalence and Related Ophthalmological Variables. Acta Ophthalmol Scand 2007;85:822-7.
10. Young AL, Tang WWT, Lam DSC. The prevalence of pseudoexfoliation syndrome in Chinese people. Br J Ophthalmol 2004;88:193-5.
11. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007;317:1397-400.
12. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial 2003. Arch Ophthalmol 2003;121:48-56.
13. Arnarsson A, Jonasson F, Sasaki H, et al. Risk factors for nuclear lens opacifications: the Reykjavik eye study. In: Hockwin O, Kojima M, Takahashi N, et al, eds. Progress in lens and cataract research. Developments in ophthalmology. Basel: Karger AG, 2002;35:12-20.
14. Jonasson F, Arnarsson A, Peto T, et al. The prevalence of age-related maculopathy in Iceland: Reykjavik eye study. Arch Ophthalmol 2003;121:379-85. (Pubitemid 36298121)
15. Jonasson F, Damji KF, Arnarsson A, et al. Prevalence of open-angle glaucoma in Iceland: Reykjavik eye study. Eye 2003;17:747-53.
16. Jonasson F, Arnarsson A, Peto T, et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 2005;112:132-8.
17. Arnarsson A, Sverrisson T, Stefansson E, et al. Risk factors for five-year incident age-related macular degeneration: the Reykjavik eye study. Am J Ophthalmol 2006;142:419-28.
18. Arnarsson A, Damji KF, Sasaki H, et al. Pseudoexfoliation in the Reykjavik eye study: 5-year incidence and changes in related ophthalmologic variables. Am J Ophthalmol 2009;148:291-7.
19. Forsius H. Exfoliation syndrome in various ethnic populations. Acta Ophthalmologica 1988;66(suppl 184):71-85.
20. Taylor HR. The environment and the lens. Br J Ophthalmol 1980;64:303-10.
21. Thomas R, Nirmalan PK, Krishnaiah S. Pseudoexfoliation in Southern India: the Andhra Pradesh eye disease study. Invest Ophthal Vis Sci 2005;46:1170-6.
22. Miyazaki M, Kubota T, Kubo M, et al. The prevalence of pseudoexfoliation syndrome in a Japanese Population: the Hisayama Study. J Glaucoma 2005;14:482-4.
23. Shingleton BJ, Heltzer J, O'Donoghue MW. Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surgery 2003;29:1080-6.
24. Tarkkanen A, Reunanen A, Kivelä T. Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmologica 2008;86:598-602.
25. Kassoff A, Kassoff J, Buehler J, et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, betacarotene and zink for age-related macular degeneration and vision loss: AREDS report no 8. Arch Ophthalmol 2001;119:1417-36.